the future of adapt-001 in patients with solid tumors refractory to checkpoint inhibitors
Published 1 month ago • 44 plays • Length 0:37Download video MP4
Download video MP3
Similar videos
-
0:48
phase i/ii trial of adapt-001, an oncolytic virus, and a checkpoint inhibitor in solid tumors
-
0:38
development of adapt-001, a novel tgf-β-trap-enhanced oncolytic virus
-
45:59
immune checkpoint inhibitors in solid tumours
-
0:26
asco 2024 - mayhem for tumors with adapt-001
-
1:44
immune checkpoint inhibitors in mcrpc
-
8:17
immune checkpoint inhibitors
-
3:03
apa itu imunoterapi? - dr. shum weng yoon - mahkota medical centre
-
2:23
iprotin - 載脂蛋白b分析卡匣組 操作影片 (apob - 預測個體冠心病風險的生物標記)
-
5:33
cancer immune checkpoint inhibitors
-
58:49
curing metastatic solid tumours with immune checkpoint inhibitors by professor james larkin
-
1:20
resistance to immune checkpoint blockade in patients with cscc
-
3:39
foxc1 as a novel prognostic biomarker in immune checkpoint inhibitor therapy
-
3:30
side effects of immune checkpoint inhibitors
-
0:18
future research directions for the novel pd-1 and ctla-4 bispecific checkpoint inhibitor, medi5752
-
0:37
immune checkpoint inhibitors: shaping the future of lymphoma
-
1:15
overcoming immune checkpoint inhibitor resistance in kidney cancer
-
3:18
immune checkpoint inhibitors and combination strategies for patients with gastric cancer
-
0:55
enhancing the efficacy of immune checkpoint inhibitors in crc
-
4:58
expert report on neoadjuvant immune checkpoint inhibitors for melanoma
-
3:48
overcoming resistance to immune checkpoint inhibitors in nsclc
-
1:23
the role of immune checkpoint inhibitors in mcrpc
-
14:32
evaluating the use of immune checkpoint inhibitors in melanoma